Cartesian Therapeutics, Inc.
RNAC
$8.63
-$0.08-0.86%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 118.64M | 125.14M | 143.38M | 160.32M | 180.43M |
| Total Receivables | 261.00K | 1.12M | 722.00K | 354.00K | 1.77M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.14M | 3.02M | 3.15M | 2.72M | 2.92M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 122.04M | 129.28M | 147.26M | 163.40M | 185.12M |
|
|
|||||
| Total Current Assets | 122.04M | 129.28M | 147.26M | 163.40M | 185.12M |
| Net Property, Plant & Equipment | 17.00M | 17.79M | 17.37M | 17.45M | 15.53M |
| Long-term Investments | 48.16M | 48.16M | 48.16M | 48.16M | 48.16M |
| Goodwill | 48.16M | 48.16M | 48.16M | 48.16M | 48.16M |
| Total Other Intangibles | 93.90M | 93.90M | 150.60M | 150.60M | 150.60M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 7.29M | 7.29M | 7.29M | 7.29M | 7.72M |
| Total Assets | 288.39M | 296.41M | 372.68M | 388.89M | 409.13M |
|
|
|||||
| Total Accounts Payable | 1.60M | 1.29M | 2.23M | 454.00K | 2.10M |
| Total Accrued Expenses | 9.07M | 9.16M | 7.60M | 7.32M | 8.67M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.19M | 4.15M | 3.88M | 3.79M | 3.70M |
| Total Finance Division Other Current Liabilities | 1.09M | 338.00K | 107.00K | 688.00K | 531.00K |
| Total Other Current Liabilities | 1.09M | 338.00K | 107.00K | 688.00K | 531.00K |
| Total Current Liabilities | 15.95M | 14.94M | 13.80M | 12.26M | 15.00M |
|
|
|||||
| Total Current Liabilities | 15.95M | 14.94M | 13.80M | 12.26M | 15.00M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 7.67M | 8.53M | 8.73M | 9.56M | 10.36M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 412.90M | 399.19M | 385.99M | 369.61M | 405.56M |
| Total Liabilities | 436.51M | 422.65M | 408.52M | 391.42M | 430.92M |
|
|
|||||
| Common Stock & APIC | 718.02M | 700.71M | 698.54M | 695.95M | 692.58M |
| Retained Earnings | -861.56M | -822.37M | -729.80M | -693.90M | -709.78M |
| Treasury Stock & Other | -4.58M | -4.58M | -4.59M | -4.58M | -4.59M |
| Total Common Equity | -148.12M | -126.24M | -35.84M | -2.53M | -21.79M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -148.12M | -126.24M | -35.84M | -2.53M | -21.79M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -148.12M | -126.24M | -35.84M | -2.53M | -21.79M |
|
|
|||||